HR 5133 United States House · 119th Congress

Patients’ Right to Know Their Medication Act of 2025

HR 5133, the Patients’ Right to Know Their Medication Act of 2025, requires drug manufacturers to provide standardized printed patient medication information (PMI) with each prescription dispensed in non-hospital settings. This PMI must include clear, plain-language details on drug name, usage instructions, warnings, side effects, storage, disposal, and interactions - formatted consistently with readable text and graphics. The bill directly affects patients receiving prescriptions, ensuring they get accessible, non-promotional printed information to improve safety and reduce errors. The FDA would establish regulations within one year of enactment, mandating that manufacturers include this standardized PMI on prescription drug packaging.
Bill status in committee 1 of 4 stages cleared
Introduction
Sep 2025
Committee Review
Floor Vote
President
Introduced Sep 4, 2025 Last action Sep 4, 2025
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
1
Sep 4, 2025
Committee
Referred to the House Committee on Energy and Commerce.
lower
Sep 4, 2025
Introduced
Introduced in House
lower
1 primary · 11 co-sponsors

Sponsors